Gp Act Iii Acquisition Stock Fundamentals
| GPAT Stock | 10.11 0.03 0.30% |
GP Act III Acquisition fundamentals help investors to digest information that contributes to GP Act's financial success or failures. It also enables traders to predict the movement of GPAT Stock. The fundamental analysis module provides a way to measure GP Act's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GP Act stock.
GPAT |
GP Act III Acquisition Company Shares Owned By Institutions Analysis
GP Act's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current GP Act Shares Owned By Institutions | 40.32 % |
Most of GP Act's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GP Act III Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 40.32% of GP Act III Acquisition are shares owned by institutions. This is 35.57% higher than that of the Financial Services sector and significantly higher than that of the Financials industry. The shares owned by institutions for all United States stocks is 2.83% lower than that of the firm.
GP Act III Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GP Act's current stock value. Our valuation model uses many indicators to compare GP Act value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GP Act competition to find correlations between indicators driving GP Act's intrinsic value. More Info.GP Act III Acquisition is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in shares outstanding category among its peers creating about 0.08 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for GP Act III Acquisition is roughly 12.60 . Common Stock Shares Outstanding is likely to drop to about 25 M in 2024. Comparative valuation analysis is a catch-all technique that is used if you cannot value GP Act by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.GPAT Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GP Act's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GP Act could also be used in its relative valuation, which is a method of valuing GP Act by comparing valuation metrics of similar companies.GP Act is currently under evaluation in shares owned by institutions category among its peers.
GPAT Fundamentals
| Current Valuation | 362.14 M | ||||
| Shares Outstanding | 28.75 M | ||||
| Shares Owned By Institutions | 40.32 % | ||||
| Number Of Shares Shorted | 3.41 K | ||||
| Price To Book | 1.30 X | ||||
| EBITDA | (14.04 K) | ||||
| Net Income | (14.04 K) | ||||
| Total Debt | 628.18 K | ||||
| Book Value Per Share | (0.02) X | ||||
| Cash Flow From Operations | (10.97 K) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | 0.15 X | ||||
| Market Capitalization | 362.25 M | ||||
| Total Asset | 530.24 K | ||||
| Retained Earnings | (122.94 K) | ||||
| Working Capital | (624.87 K) | ||||
| Net Asset | 530.24 K |
About GP Act Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GP Act III Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GP Act using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GP Act III Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.